All News #Library
Biotech
Grid Therapeutics begins Phase II trial of NSCLC therapy
24 Feb 2023 //
CLINICAL TRIALS ARENA
Grid Initiates PII Investigator-Sponsored Trial of GT103 with Pembrolizumab
22 Feb 2023 //
BUSINESSWIRE

Market Place
Sourcing Support